Huawei Tops China Smartphone Sales Leading to 618 Festival, up 42.4% y/y

01 September 2022, Berlin: The logo of Huawei at the electronics fair IFA. (dpa)
01 September 2022, Berlin: The logo of Huawei at the electronics fair IFA. (dpa)
TT

Huawei Tops China Smartphone Sales Leading to 618 Festival, up 42.4% y/y

01 September 2022, Berlin: The logo of Huawei at the electronics fair IFA. (dpa)
01 September 2022, Berlin: The logo of Huawei at the electronics fair IFA. (dpa)

Chinese phone maker Huawei lead in smartphone sales in China in the May 20-June 16 period that coincided with the 618 shopping festival, selling 42.4% more than a year ago, Counterpoint Research said on Tuesday.

Huawei's sales were driven by continued demand for its new 5G products, said the research firm, which covers the technology, media and telecom industry.

Total smartphone sales in China rose 6.8% during the period compared with a year before, with Xiaomi's sales higher by nearly 12.6% and Apple's sales up 2.7%.



Intuitive Surgical Results Beat on Growing Demand for Surgical Robots

Representation photo: Employees work at the office of humanoid robots developer Ex-Robots in Dalian, Liaoning province, China June 6, 2024. REUTERS/Florence Lo
Representation photo: Employees work at the office of humanoid robots developer Ex-Robots in Dalian, Liaoning province, China June 6, 2024. REUTERS/Florence Lo
TT

Intuitive Surgical Results Beat on Growing Demand for Surgical Robots

Representation photo: Employees work at the office of humanoid robots developer Ex-Robots in Dalian, Liaoning province, China June 6, 2024. REUTERS/Florence Lo
Representation photo: Employees work at the office of humanoid robots developer Ex-Robots in Dalian, Liaoning province, China June 6, 2024. REUTERS/Florence Lo

Intuitive Surgical on Thursday beat estimates for second-quarter profit and revenue on growing demand for its surgical robots used in minimally invasive procedures, sending its shares up 6.7% after the bell.
Investor expectations around medical device makers have grown lately on hopes of elevated demand for surgical procedures as people, especially older adults, opt for medical procedures deferred during the pandemic, Reuters said.
On an adjusted basis, Intuitive earned $1.78 per share for the quarter ended June 30, beating analysts' estimates of $1.54 per share, according to LSEG data.
The company reported quarterly revenue of $2.01 billion, compared with analysts' estimates of $1.97 billion.
The rise in revenue was driven in part by growth in the procedure volume from the company's surgical robots called da Vinci. Worldwide da Vinci procedure volumes rose about 17%, from a year ago, the company said.
Industry bellwether Johnson & Johnson on Wednesday posted a 2.2% rise in second quarter sales at its medical technology business, but fell short of analysts' estimates.
Larger peer Abbott Laboratories also raised its annual profit forecast, helped by double-digit growth in sales of its glucose monitors and strong demand for heart devices.